Correlation Between Neurocrine Biosciences and Bausch
Specify exactly 2 symbols:
By analyzing existing cross correlation between Neurocrine Biosciences and Bausch Health Companies, you can compare the effects of market volatilities on Neurocrine Biosciences and Bausch and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Bausch. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Bausch.
Diversification Opportunities for Neurocrine Biosciences and Bausch
0.82 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Neurocrine and Bausch is 0.82. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Bausch Health Companies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bausch Health Companies and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Bausch. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bausch Health Companies has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Bausch go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Bausch
Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.18 times more return on investment than Bausch. However, Neurocrine Biosciences is 1.18 times more volatile than Bausch Health Companies. It trades about 0.13 of its potential returns per unit of risk. Bausch Health Companies is currently generating about 0.07 per unit of risk. If you would invest 11,775 in Neurocrine Biosciences on September 23, 2024 and sell it today you would earn a total of 1,767 from holding Neurocrine Biosciences or generate 15.01% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 80.0% |
Values | Daily Returns |
Neurocrine Biosciences vs. Bausch Health Companies
Performance |
Timeline |
Neurocrine Biosciences |
Bausch Health Companies |
Neurocrine Biosciences and Bausch Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Neurocrine Biosciences and Bausch
The main advantage of trading using opposite Neurocrine Biosciences and Bausch positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Bausch can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bausch will offset losses from the drop in Bausch's long position.Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. Collegium Pharmaceutical | Neurocrine Biosciences vs. Ironwood Pharmaceuticals | Neurocrine Biosciences vs. ANI Pharmaceuticals |
Bausch vs. Grupo Simec SAB | Bausch vs. Kaiser Aluminum | Bausch vs. Sapiens International | Bausch vs. Sanyo Special Steel |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |